14 October 2025 - 17 October 2025
MA 02114 Boston, United States
5 Blossom Street
Wyndham Boston Beacon Hill
Pharma Partnering, Drug Safety & PPM Summit Boston
Future of Pharmacovigilance
Our prestigious American Drug Safety Summit, a cornerstone of our Pharmacovigilance World Tour.
-
Join America’s Leading Drug Safety Professionals
-
America’s Leading Drug Safety Professionals
-
Gain insights into the most pressing issues facing drug safety today
-
Discuss the vision for 2025 and lessons of 2024
-
Listen to the most crucial current topics selected & presented by industry leaders
-
Enjoy education & networking focused event in a non-vendor-driven environment
-
Create lasting work groups and friendships with the possibility of meeting regularly on the next stops of our world tour
You will spend your time with
-
Pharmacovigilance Executives
-
Regulatory Affairs Professionals
-
Quality Assurance Specialists
-
Drug Safety Officers
-
Clinical Research Leaders
VPs, Global Heads and Senior Directors of:
-
Drug Safety
-
Pharmacovigilance
-
Risk Management
-
Signal Detection
-
Regulatory & Compliance
-
Post-market research
-
PV audit
-
Digitization
-
Automation
-
Operations
Always ask WHY?
Creating contrast to loud, expo- style meetings with limited focus and personal touch, WHY SUMMITS World tour of Pharmacovigilance conferences brings another kind of experience. Our Boston Knowledge-Focused Meeting will cover the following emerging topics:
-
Strengthening REMS & Risk Mitigation Strategies
-
Tech Innovation: Digital Solutions for Risk Management
-
Evolving REMS Programs & Regulatory Expectations
-
Risk-Based Decision Making in Pharmacovigilance
-
AI in REMS: The Future of Safety Monitoring
-
Risk Communication & Stakeholder Collaboration
-
Post-Market Risk Management Best Practices
-
Future of REMS & Global Risk Management Regulations
-
The Next Decade of REMS & Risk Management
-
The Power of Cross-Functional Collaboration in PV
-
Enhancing PV Operations with AI & Automation
-
AI-Driven Signal Detection & Risk Prediction
-
The Business Case for AI in Pharmacovigilance
-
Optimizing Safety Signal Management through Collaboration
-
The Role of Real-World Evidence